Market Place
Sourcing Support
Invivyd Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
06 Apr 2026 //
GLOBENEWSWIRE
Invivyd Names Michael Mina, M.D., Ph.D. Chief Medical Officer
05 Mar 2026 //
GLOBENEWSWIRE
Invivyd Reports Q4 and FY 2025 Results, Declaration Updates
05 Mar 2026 //
GLOBENEWSWIRE
Invivyd Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
02 Mar 2026 //
GLOBENEWSWIRE
Invivyd Teams Up With Lindsey Vonn For Antibody Education
22 Jan 2026 //
FIERCE PHARMA
Invivyd Reveals Q4 2025 Revenue And Business Updates
08 Jan 2026 //
GLOBENEWSWIRE
Invivyd To Present At 8Th Evercore Healthcare Conference
25 Nov 2025 //
GLOBENEWSWIRE
Invivyd Announces Proposed Public Offering Of Common Stock
17 Nov 2025 //
GLOBENEWSWIRE
Invivyd To Host Q3 2025 Financial Results Call On November 6
03 Nov 2025 //
GLOBENEWSWIRE
Invivyd Names Kristie Kuhl Chief Communications Officer
17 Sep 2025 //
GLOBENEWSWIRE
Invivyd to Participate in Upcoming Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Invivyd Closes $57.5M Public Offering, Underwriter Extra Shares
22 Aug 2025 //
GLOBENEWSWIRE
Invivyd Proposes Public Offering of Common Stock
20 Aug 2025 //
GLOBENEWSWIRE
Invivyd Prices $50M Public Offering of Stock & Pre-Funded Warrant
20 Aug 2025 //
GLOBENEWSWIRE
Invivyd Reports Q1 2025 Financial Results and Business Highlights
15 May 2025 //
GLOBENEWSWIRE
Invivyd to Attend H.C. Wainwright BioConnect Investor Conference
13 May 2025 //
GLOBENEWSWIRE
Invivyd to Host Q1 2025 Financial Results Conference Call
08 May 2025 //
GLOBENEWSWIRE
Invivyd secures $30M loan from Silicon Valley Bank
21 Apr 2025 //
GLOBENEWSWIRE
Invivyd Reports 2024 Financial Results and Business Highlights
20 Mar 2025 //
GLOBENEWSWIRE
Invivyd to Present at Oppenheimer 35th Annual Healthcare Conference
10 Feb 2025 //
GLOBENEWSWIRE
Invivyd Announces Revenue Growth in Preliminary Q4 2024 Results
03 Feb 2025 //
GLOBENEWSWIRE
Invivyd Reports Q3 2024 Financial Results & Highlights
14 Nov 2024 //
GLOBENEWSWIRE
Invivyd to Host Q3 2024 Financial Results & Update Conference Call
06 Nov 2024 //
GLOBENEWSWIRE
Invivyd Updates PEMGARDA™ EUA Fact Sheet with Variant Data
01 Oct 2024 //
GLOBENEWSWIRE
Invivyd Shares PEMGARDA SARS-CoV-2 Neutralization Data
23 Sep 2024 //
GLOBENEWSWIRE
Invivyd Reports Continued Activity of PEMGARDA Against SARS-CoV-2 Variants
03 Sep 2024 //
GLOBENEWSWIRE
Invivyd To Host Q2 2024 Results And Business Highlights Call
12 Aug 2024 //
GLOBENEWSWIRE
Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
01 Jul 2024 //
GLOBENEWSWIRE
Invivyd to Participate at the Jefferies Global Healthcare Conference
03 Jun 2024 //
GLOBENEWSWIRE
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
31 May 2024 //
GLOBENEWSWIRE
Invivyd At ASCO And American Transplant Congress 2024
29 May 2024 //
GLOBENEWSWIRE
Invivyd Elects Two New Independent Members to its Board of Directors
22 May 2024 //
GLOBENEWSWIRE
Invivyd At HC Wainwright BioConnect Conference
13 May 2024 //
GLOBENEWSWIRE
Invivyd Q1 2024 Financials And Business Highlights
09 May 2024 //
GLOBENEWSWIRE
Invivyd Q1 2024 Results, Business Highlights Call
02 May 2024 //
GLOBENEWSWIRE
Invivyd Gets HCPCS Codes For PEMGARDA™ From CMS
15 Apr 2024 //
GLOBENEWSWIRE
Invivyd Announces CEO Transition
12 Apr 2024 //
GLOBENEWSWIRE
Invivyd Provides PEMGARDA Launch Update
04 Apr 2024 //
GLOBENEWSWIRE
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
28 Mar 2024 //
GLOBENEWSWIRE
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Conference
05 Feb 2024 //
GLOBENEWSWIRE
Invivyd Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Invivyd to Participate in Upcoming Investor Conferences
31 Oct 2023 //
GLOBENEWSWIRE
Invivyd to Participate in Upcoming Investor Conferences
06 Sep 2023 //
GLOBENEWSWIRE
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
10 Aug 2023 //
GLOBENEWSWIRE
Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Invivyd Announces Appointment of Sara Cotter to Board Of Directors
27 Jul 2023 //
GLOBENEWSWIRE
Invivyd to Participate at the Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
11 May 2023 //
GLOBENEWSWIRE
Invivyd to Host Conference Call Discussing 1Q 2023 FYR and Business Highlights
04 May 2023 //
GLOBENEWSWIRE
Invivyd to Participate at H.C. Wainwrightâ BioConnect Investor Conference
25 Apr 2023 //
GLOBENEWSWIRE
Invivyd Appoints Robert Allen as CSO and Stacy Price as Chief Technology Officer
12 Apr 2023 //
GLOBENEWSWIRE
Invivyd Reports Full Year 2022 Financial Results and Business Highlights
23 Mar 2023 //
GLOBENEWSWIRE
Invivyd to Participate at Cowen’s 43rd Annual Healthcare Conference
28 Feb 2023 //
GLOBENEWSWIRE
Invivyd Announces Changes to Executive Team
03 Feb 2023 //
GLOBENEWSWIRE
Invivyd Presented Industry Rationale on Potential Expedited Development Pathway
19 Dec 2022 //
GLOBENEWSWIRE
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer
06 Dec 2022 //
GLOBENEWSWIRE
Invivyd Announces Partnership With Population to Accelerate Clinical Devp
17 Nov 2022 //
GLOBENEWSWIRE
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
10 Nov 2022 //
GLOBENEWSWIRE
Invivyd to Host Conference on November 10 to Discuss Q3 2022 Financial Results
02 Nov 2022 //
GLOBENEWSWIRE
